Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)
National Institutes of Health · Oral Diseases and Disorders Research (93.121)
Опубликован 6 окт. 2026 г. · Осталось примерно 33 месяца
Краткое описание
Исходный текст донора (английский)
The purpose of this notice of funding opportunity (NOFO) is to support implementation research on strategies to improve the uptake, implementation, sustainment, scale and/or spread of evidence-based prevention, treatment, and care interventions in communities in the U.S. significantly impacted by HIV. Projects should be large in scale with high potential for research and public health impact. Specifically, large single site studies, multi-site studies, and comparative studies are encouraged as scientifically appropriate.
Фрагмент со страницы донора. Полный текст, приложения и формы — в исходном объявлении о конкурсе.
Требования и условия
Показать требования из источника · Исходный текст донора (английский)
Applicant types: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; City or township governments; Independent school districts; Special district governments; Public and State controlled institutions of higher education; Native American tribal governments (Federally recognized); County governments; Public housing authorities/Indian housing authorities; Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; Small businesses
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).